Most Medicare Part D plans include coverage for Repatha, though specific coverage details can vary among plans. Out-of-pocket costs for Repatha under Medicare Part D typically average around $49 per ...
MSD has fleshed out the results of phase 3 trials of its cholesterol-lowering, oral PCSK9 inhibitor, enlicitide decanoate, showing its efficacy was comparable to that of injectable alternatives. The ...
High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...
Q. My doctor prescribed rosuvastatin for high cholesterol. After taking it for six to nine months, I noticed that my cognitive function had slipped. I would not be able to find the word I was looking ...
TrumpRx is set to launch soon. President Donald Trump has been pressuring drug companies to lower prices. Americans currently pay about three times more for prescription medicine than patients in ...
Amgen's acquisition of Dark Blue Therapeutics adds a small molecule targeting MLLT1/3 proteins in AML, enhancing its oncology portfolio. Amgen is committed to reducing drug costs, expanding its ...
US names HIV, arthritis drugs for next Medicare price talks The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results